CN Bio Innovations

CN Bio Innovations CN Bio develops microfluidic Organ-on-Chip devices that mimic human organ structure and function in the laboratory.

Backed by a $26M US Federal contract to develop a Human body-on-a-chip and building on technologies developed at the Massachusetts Institute of Technology, CN Bio is one of the pre-eminent Organ-on-Chip firms in this emerging field.

06/03/2020

A thought-provoking report on what researchers really think about the culture they work in. What are your thoughts on the research culture in the UK? (Wellcome Trust)

https://bit.ly/38PQ0BS

[Summary] Perspectives on and experiences of research culture, based on a survey of more than 4,000 researchers in the UK and globally.

The European Commission this month reported that 10 million animals are used in research, testing and education in the E...
05/03/2020

The European Commission this month reported that 10 million animals are used in research, testing and education in the EU every year. A further 12.6 million are bred for use in science, but are killed without being included in an experiment.

https://bit.ly/2SGMuUr

Reports released today by the European Commission show that the fast progress towards humane, animal-free research that citizens expect is not being made. Not only that, but many Member States need to make significant improvements in the way they are implementing and enforcing the requirements of Di...

According to their paper recently published in Nature Communications, a team from London have developed a 3D hydrogel sy...
04/03/2020

According to their paper recently published in Nature Communications, a team from London have developed a 3D hydrogel system that can be used to grow human organoids for use in the clinic...

Organoid cultures have been developed from multiple tissues, opening new possibilities for regenerative medicine. Here the authors demonstrate the derivation of GMP-compliant hydrogels from decellularized porcine small intestine which support formation and growth of human gastric, liver, pancreatic....

04/03/2020

Our PhysioMimix OOC plates are compatible with commercial inserts, tissue-specific scaffords and spheroidal cultures

Researchers from the MRC London Institute of Medical Sciences and the Institute of Psychiatry, Psychology & Neuroscience...
03/03/2020

Researchers from the MRC London Institute of Medical Sciences and the Institute of Psychiatry, Psychology & Neuroscience, King's College London have identified a synaptic protein that is present at lower levels in the front part of the brain, the part used for planning, in individuals with schizophrenia compared to those without. This protein is a potential target for future disease treatments

https://bit.ly/39P8Lp4

We are creating a unified UKRI website that brings together the existing research council, Innovate UK and Research England websites. If you would like to be involved in its development let us know.

02/03/2020

Pharmaceutical companies spend vast amounts of money on R&D of new drug candidates, which often fail in early-phase human trials. CN Bio Innovations' technology platform and services allow testing of drug effects on the targeted organs as well as off-target effects on other organs before commencing human trials

https://cn-bio.com/

At the end of last year, 16 technologies were selected for 'The Medicine Maker 2019 Innovation Awards'. You have until M...
28/02/2020

At the end of last year, 16 technologies were selected for 'The Medicine Maker 2019 Innovation Awards'. You have until March 11 to vote for the one you think is the most groundbreaking... (The Medicine Maker)

https://bit.ly/38BCbGQ

At the end of 2019 we celebrated The Medicine Maker 2019 Innovation Awards. But which technology is truly the most innovative?

27/02/2020

Despite more than 750 trials relating to NAFLD to date, no approved treatments are available. NASH, an aggressive inflammatory manifestation of NAFLD, is becoming increasingly prevalent and represents a looming global health crisis. This article by Drug Discovery World explains why the clinical trial results have been disappointing

https://bit.ly/2QMfIRr

Our Organ-on-chip technology is particularly relevant for examining cellular changes that occur during cancer developmen...
27/02/2020

Our Organ-on-chip technology is particularly relevant for examining cellular changes that occur during cancer development, which may be species-specific

Contact us today to learn more:

https://lnkd.in/dfaGZRm

Address

332 Cambridge Science Park, Milton Road
Cambridge
CB40WN

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5:30pm

Telephone

+441223737941

Alerts

Be the first to know and let us send you an email when CN Bio Innovations posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to CN Bio Innovations:

Featured

Share